Risk factors for treatment failure in scabies: a cohort study

被引:31
|
作者
Aussy, A. [1 ,2 ]
Houivet, E. [3 ,4 ]
Hebert, V. [1 ,2 ]
Colas-Cailleux, H. [1 ,2 ]
Laaengh, N. [1 ,2 ]
Richard, C. [1 ,2 ]
Ouvry, M. [1 ,2 ]
Boulard, C. [1 ,2 ]
Leger, S. [1 ,2 ]
Litrowski, N. [1 ,2 ]
Benichou, J. [3 ,4 ]
Joly, P. [1 ,2 ]
Bechu, S.
Mion-Mouton, N.
Lafaurie, O.
Barrel, A.
Pulluard, M.
Hamel, V.
Dore, M. X.
Duflo, E.
Lardans-Cassius, S.
Rzeznik, J. C.
Baricault, S.
机构
[1] Rouen Univ Hosp, Dept Dermatol, Rouen, France
[2] Univ Rouen Normandie, INSERM, U1234, Rouen, France
[3] Rouen Univ Hosp, Dept Biostat, Rouen, France
[4] Univ Rouen Normandie, INSERM, U1219, Rouen, France
关键词
ORAL IVERMECTIN; PREVALENCE; EPIDEMIOLOGY; CREAM;
D O I
10.1111/bjd.17348
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Treatment failure, which occurs in about one-third of cases, is considered as a major factor in the increasing incidence of scabies in developed countries. Objectives To identify predictors of treatment failure of scabies in ambulatory populations. Methods This multicentre study compared the clinical characteristics and treatment modalities between a group of patients with scabies treated successfully and another group who were not cured 3 months after antiscabies treatment. Results In total 210 patients with a diagnosis of scabies were included, comprising 98 patients in the treatment success group and 112 in the treatment failure group. The main risk factors for treatment failure were (i) the use of only one type of treatment, topical benzyl benzoate (BB) or oral ivermectin, vs. the combination of both treatments [odds ratio (OR) 2 center dot 15, 95% confidence interval (CI) 1 center dot 22-3 center dot 77]; (ii) the use of a single intake (vs. two) of oral ivermectin (OR 10 center dot 2. 95% CI 4 center dot 49-23 center dot 2); (iii) intake of ivermectin during a meal vs. on an empty stomach (OR 4 center dot 31, 95% CI 1 center dot 89-9 center dot 84); (iv) absence of decontamination of furnishings (OR 8 center dot 72, 95% CI 3 center dot 50-21 center dot 8), in particular sofa and cushions (OR 5 center dot 90, 95% CI 2 center dot 34-14 center dot 9), mattresses (OR 4 center dot 16, 95% CI 1 center dot 35-12 center dot 8) or car seats (OR 6 center dot 57, 95% CI 3 center dot 27-13 center dot 2) and (v) absence of written documents explaining treatment modalities (OR 5 center dot 18, 95% CI 2 center dot 57-10 center dot 4). In multivariate analysis, treatment failure was mainly associated with (i) use of a single intake (vs. two) of ivermectin (OR 6 center dot 62, 95% CI 2 center dot 71-16 center dot 2); (ii) use of BB alone vs. two intakes of ivermectin (OR 3 center dot 51, 95% CI 1 center dot 55-7 center dot 95) and (iii) absence of decontamination of furniture with acaricides (OR 5 center dot 81, 95% CI 1 center dot 96-16 center dot 7). Conclusions Use of topical BB alone and a single intake (vs. two) of ivermectin are predictors of treatment failure.
引用
收藏
页码:888 / 893
页数:6
相关论文
共 50 条
  • [21] Increase the risk of intellectual disability in children with scabies: A nationwide population-based cohort study
    Liu, Jui-Ming
    Hsu, Ren-Jun
    Chang, Fung-Wei
    Yeh, Chia-Lun
    Huang, Chun-Fa
    Chang, Shu-Ting
    Chiu, Nan-Chang
    Chang, Hung-Yang
    Chi, Hsin
    Lin, Chien-Yu
    MEDICINE, 2017, 96 (23)
  • [22] Metabolic factors and hip fracture risk in a large Austrian cohort study
    Dominic, Erlangga
    Brozek, Wolfgang
    Peter, Raphael Simon
    Fromm, Ella
    Ulmer, Hanno
    Rapp, Kilian
    Concin, Hans
    Nagel, Gabriele
    BONE REPORTS, 2020, 12
  • [23] Risk factors for constipation during pregnancy: a multicentre prospective cohort study
    Sabonyte-Balsaitiene, Zivile
    Poskus, Tomas
    Jasiunas, Eugenijus
    Ramasauskaite, Diana
    Buzinskiene, Diana
    Drasutiene, Grazina
    Okuleviciute, Agne
    Zakareviciene, Jolita
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [24] Lifestyle Factors and Risk of Restless Legs Syndrome: Prospective Cohort Study
    Batool-Anwar, Salma
    Li, Yanping
    De Vito, Katerina
    Malhotra, Atul
    Winkelman, John
    Gao, Xiang
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2016, 12 (02): : 187 - 194
  • [25] Scabies is strongly associated with acute rheumatic fever in a cohort study of Auckland children
    Thornley, Simon
    Marshall, Roger
    Jarrett, Paul
    Sundborn, Gerhard
    Reynolds, Edwin
    Schofield, Grant
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (06) : 625 - 632
  • [26] Incidence and Risk Factors for Progression to Diabetes Mellitus: A Retrospective Cohort Study
    Hyun, Min Kyung
    Park, Jong Heon
    Kim, Kyoung Hoon
    Ahn, Soon-Ki
    Ji, Seon Mi
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (01)
  • [27] Risk factors for abnormal glucose metabolism during antipsychotic treatment: A prospective cohort study
    Miyakoshi, Takashi
    Ishikawa, Shuhei
    Okubo, Ryo
    Hashimoto, Naoki
    Sato, Norihiro
    Kusumi, Ichiro
    Ito, Yoichi M.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 168 : 149 - 156
  • [28] Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study
    Jacobse, Judy N.
    Schaapveld, Michael
    Boekel, Naomi B.
    Hooning, Maartje J.
    Jager, Agnes
    Baaijens, Margreet H. A.
    Hauptmann, Michael
    Russell, Nicola S.
    Rutgers, Emiel J. T.
    Aleman, Berthe M. P.
    Sonke, Gabe S.
    van Leeuwen, Flora E.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 205 - 214
  • [29] Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study
    Judy N. Jacobse
    Michael Schaapveld
    Naomi B. Boekel
    Maartje J. Hooning
    Agnes Jager
    Margreet H. A. Baaijens
    Michael Hauptmann
    Nicola S. Russell
    Emiel J. T. Rutgers
    Berthe M. P. Aleman
    Gabe S. Sonke
    Flora E. van Leeuwen
    Breast Cancer Research and Treatment, 2021, 185 : 205 - 214
  • [30] Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study
    Landgren, A. J.
    Jacobsson, L. T. H.
    Lindstrom, U.
    Sandstrom, T. Z. S.
    Drivelegka, P.
    Bjorkman, L.
    Fjellstedt, E.
    Dehlin, M.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19